Close Menu

NEW YORK­ – Biocept said Thursday that it entered into a securities purchase agreement on March 4 with several institutional investors for the issuance and sale of 16,000,000 shares of its common stock at a price of $.41 per share, for gross proceeds of approximately $6.6 million in a registered direct offering priced at the market.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.